nobiletin has been researched along with Fibrosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dobashi, A; Imada, K; Ito, A; Miyata, Y; Sato, T; Yano, M | 1 |
| Hirata, M; Ito, A; Koike, L; Mimaki, Y; Miyata, Y; Sashida, Y; Sato, T; Yano, M | 1 |
2 other study(ies) available for nobiletin and Fibrosarcoma
| Article | Year |
|---|---|
A citrus polymethoxyflavonoid, nobiletin, is a novel MEK inhibitor that exhibits antitumor metastasis in human fibrosarcoma HT-1080 cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Citrus; Dose-Response Relationship, Drug; Enzyme Activation; Fibrosarcoma; Flavones; Humans; Mitogen-Activated Protein Kinases; Plant Extracts | 2008 |
Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix meta
Topics: Anticarcinogenic Agents; Chromones; Enzyme Inhibitors; Fibrosarcoma; Flavones; Flavonoids; Humans; Matrix Metalloproteinase 1; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Morpholines; Neoplasm Invasiveness; NF-kappa B; Phosphoinositide-3 Kinase Inhibitors; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1; Transcription Factor AP-1; Tumor Cells, Cultured | 2002 |